期刊
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
卷 11, 期 3, 页码 238-248出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138620708783877753
关键词
high throughput; screening; Huntington's disease; drugs; neurodegeneration; high-content; aggregation; cell death
High throughput screening (HTS) for complex diseases is challenging. This stems from the fact that complex phenotypes are difficult to adapt to rapid, high throughput assays. We describe the recent development of high throughput and high-content screens (HCS) for neurodegenerative diseases, with a focus on inherited neurodegenerative disorders, such as Huntington's disease. We describe, among others, HTS assays based on protein aggregation, neuronal death, caspase activation and mutant protein clearance. Furthermore, we describe high-content screens that are being used to prioritize hits identified in such HTS assays. These assays and screening approaches should accelerate drug discovery for neurodegenerative disorders and guide the development of screening approaches for other complex disease phenotypes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据